Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem
- Conditions
- Total Hip Arthroplasty
- Interventions
- Procedure: Total Hip Arthroplasty
- Registration Number
- NCT01566916
- Lead Sponsor
- Rothman Institute Orthopaedics
- Brief Summary
This prospective, randomized study will study the 2 year survivorship and short term outcomes of a currently-used femoral stem: the Bone Preservation Tri-Lock femoral stem using two surgical approaches. The surgical approaches being studied are direct anterior and anterolateral. Implant survivorship, radiographic positioning, and functional outcomes will be compared. Subjects will be randomized to surgical approach and followed for a period of two years.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
- Patient signed an IRB, study specific informed patient consent
- Patient is a male or non-pregnant female age 21 years or older at the time of study device implantation
- Patient has primary diagnosis of non-inflammatory degenerative joint disease.
- Patient is a candidate for primary cementless total hip replacement
- Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
- Patient has a Body Mass Index (BMI) > 40 Kg/m2
- Patient has an active or suspected infection at the time of device implantation
- Patient is immunologically suppressed.
- Patient requires revision surgery of a previously implanted total hip replacement
- Patient has a known sensitivity to device materials
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Total Hip Arthroplasty performed via direct anterior approach Total Hip Arthroplasty - Total Hip Arthroplasty using anterolateral approach Total Hip Arthroplasty -
- Primary Outcome Measures
Name Time Method Survivorship of Bone Preservation Tri-Lock femoral stem 2 years post-op Survivorship will be assessed via radiographic (x-ray) analysis and need for revision surgery (if patient had femoral stem removed for any reason within the first two years after surgery).
- Secondary Outcome Measures
Name Time Method TUG (timed up and go) Score 6 weeks post-op
Trial Locations
- Locations (1)
Rothman Institute
🇺🇸Philadelphia, Pennsylvania, United States